NEW: Nation’s Reopening Guidance Available here for Download

53

Translate to Spanish or other 102 languages!

Image Composition: Texas Border Business

Mega Doctor News

- Advertisement -

The CDC finally released long-delayed reopening guidance for schools, workplaces, camps, childcare centers, mass transit, and bars and restaurants.

  • The six one-page “decision tool” documents use traffic signs and other graphics to tell organizations what they should consider before reopening.
  • The CDC planned a document for churches, but that wasn’t posted, AP reports. The White House raised concerns about recommended restrictions.

See the checklists:

  1. Restaurants and bars
  2. Workplaces
  3. Child care
  4. Schools
  5. Youth programs and camps
  6. Mass transit

In a sign of reopening complexity, McDonald’s issued a 59-page guide for franchisees, urging them to close public soda fountains or deploy a staff member to monitor them, The Wall Street Journal reports (subscription).

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
“With COVID-19, We All Need to Be Vigilant and Not Let Our Guard Down,” – Frank Ambriz
Next article
Governor Abbott, HHSC Announce $3.6 Million To Connect Nursing Facility Residents And Families

More Articles

STHS Recognized by Healthgrades with Five-Star Rating for Gallbladder Removal Surgery

One of the most frequently performed surgeries in the United States, gallbladder removal is becoming increasingly common.

Scientists Reverse Brain Aging With a Nasal Spray

Picture this: your brain is a high-performance engine. Over decades, it doesn’t just wear down; it also starts to run hot.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 
- Advertisement -